Abstract 2101: Ormeloxifene suppresses the growth of prostate tumorviainhibition of β-catenin induced AR signaling
Abstract
Background: Prostate cancer (PrCa) first manifests as an androgen-dependent disease and can be treated with androgen-deprivation therapy. Despite the initial success of androgen ablation therapy, resistance to anti-androgen therapy displays by progression to hormone refractory (androgen-independent) advanced stage PrCa which is primary cause of patient’s death. Main underlying cause for the onset of hormone refractory cancer is ligand...
Paper Details
Title
Abstract 2101: Ormeloxifene suppresses the growth of prostate tumorviainhibition of β-catenin induced AR signaling
Published Date
Jul 1, 2017
Journal
Volume
77
Issue
13_Supplement
Pages
2101 - 2101
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History